Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

UNBELIEVABLE: Carl icahn - The Untold Story

Time on his side: Michael Dell the real business icon as Icahn the activist recedes from view

In retrospect, the titanic battle between Dell and Icahn likely marked a turning point in activist investing.

Fortune

Billionaire Scorecard: Tepper Dominates Q3, Ackman Stays Hot, Buffett Prints A Rare Red Quarter

Billionaire hedge fund results for the third quarter are in, and the shake-up is bigger than anyone expected. David Tepper walked away with the quarter, leaving even the strongest long-term performers behind.

Benzinga

Hedge Fund Billionaire Carl Icahn's Q3: The Activist Goes Defensive, Exits A Troubled Bet, And Loads Up On EchoStar

Activist hedge fund billionaire Carl Icahn may be 89, but his portfolio is moving like it's on an energy drink. The billionaire activist's latest 13F filing shows a $9.14 billion book in Q3 that looks unmistakably Icahn: concentrated, contrarian and packed with companies that most hedge funds wouldn't touch with…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

The Insider Report: The Bulls Can Thank Tech

Stocks were up across the board last week, and weathered numerous headlines including a rate cut, a trade meeting between the U.S. and China, as well as earnings season. The Nasdaq led the way higher, closing up 2.24%. The Dow Jones Industrial Average followed, closing up 0.74%. The SP 500…

Benzinga

Warren Buffett's Berkshire In Talks To Buy OxyChem For $10 Billion: Report

Berkshire Hathaway, Inc. (NYSE:BRK) (NYSE:BRK) is in talks to acquire Occidental Petroleum Corp.‘s (NYSE:OXY) chemical unit, OxyChem, in a deal valued at roughly $10 billion.

Benzinga

Leon Cooperman, David Tepper Beat Warren Buffett, Bill Ackman In Q2 Billionaire Face-Off

The second quarter delivered a jolt for hedge fund watchers, with some of Wall Street's most storied managers posting eye-catching gains.

Benzinga

Business leaders are threatening to leave New York City amid the unlikely ascension of Zohran Mamdani. This scenario has played out before—here’s what happened

By backing a platform of economic redistribution, New Yorkers are committing "suicide by Mayor," one finance analyst said.

Fortune

Read news from The Economist, FT, and more,
with one subscription

26 Companies That Were Successful Until A Single Bad Decision Wrecked Them Completely

One bad decision was all it took to wreck these successful companies.

Bored Panda

Carl Icahn Falls Short in Q1. Is It Time to Sell Icahn Enterprises Stock?

With mounting losses reported in its latest earnings release, is it time to rethink the future of Icahn Enterprises?

Barchart

3 Unusually Active Call Options to Buy for Less Than $100

here were 727 unusually active call options in Thursday trading. Of those, there were 250 for less than $100. These three were in the top 100 and are worth considering

Barchart

BofA Predicts No Rate Cuts in 2025: 3 Dividend Stocks to Watch

With Bank of America predicting no Federal Reserve rate cuts in 2025, investors may turn to high-dividend stocks for stable income and potential growth.

Barchart

Shares in UK retailers fall as sector counts cost of NICs tax rise – as it happened

Rolling coverage of the latest economic and financial news

The Guardian - UK

Jeffrey Epstein details close relationship with Trump in newly released tapes

Recordings from 2017 reveal Epstein talking for some ‘100 hours’ about the ex-president, journalist Michael Wolff says

The Guardian - US

Leaked audio appears to reveal Jeffrey Epstein detailing inner workings of Trump White House

Journalist Michael Wolff releases recording allegedly featuring late billionaire pedophile gossiping about Republican’s first administration

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis

'Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff Sonnenfeld and Steven Tian.

Fortune

Super Micro, an AI darling, postponed earnings while under a short-seller’s microscope

Hindenburg Research’s 19,000-word short report accuses Super Micro of sanctions evasion and accounting manipulation.

Fortune

he SEC fined Carl Icahn $500K—just 0.01% of his net wealth

The SEC alleges Icahn pledged approximately 51% to 82% of his holding company's outstanding securities to secure margin loans.

Top News

Icahn Targets Illumina's Legacy Directors Removal

In a daring move, visionary investor Icahn seeks to oust Illumina's old guard, asserting fresh energy is needed in a vibrant, change-chasing letter.

Barchart

Down 66%, Is This High-Yield Dividend Stock a Buy for 2024?

Helmed by a maverick activist investor, this high-yield, dividend-paying stock is down 67% on a YTD basis - but is it a good value buy right now? Here's what investors need to know.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.